Novavax vaccine 96% effective against original coronavirus, 86% vs British variant in UK trial

[brooklynite]

Reuters

(Reuters) - Novavax Inc’s COVID-19 vaccine was 96% effective in preventing cases caused by the original version of the coronavirus in a late-stage trial conducted in the United Kingdom, the company said on Thursday, moving it a step closer to regulatory approval.

There were no cases of severe illness or deaths among those who got the vaccine, the company said, in a sign that it could stop the worse effects of new variants that have cropped up.

The vaccine was 86% effective in protecting against the more contagious virus variant first discovered and now prevalent in the United Kingdom, for a combined 90% effectiveness rate overall based on data from infections of both versions of the coronavirus.

Novavax shares jumped 22% in after-hours trading to $229. They were trading below $10 on Jan. 21, 2020, when the company announced it was developing a coronavirus vaccine.

[StClone]

1. Another vaccine!

Novavax, Inc. is an American vaccine development company headquartered in Gaithersburg, Maryland, with additional facilities in Rockville, Maryland and Uppsala, Sweden.

[bullwinkle428]

2. Data from clinical trials of Novavax in the U.S. expected in early April.

[Initech]

3. More great news!

[mucifer]

4. The world needs this!!!

[Wounded Bear]

5. K&R...nt